COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 1799: Articles 17981-17990  | Next

FDA-authorized COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
Pawlowski, C., Lenehan, P., Puranik, A., Agarwal, V., Venkatakrishnan, A., Niesen, M. J., O Horo, J. C., Badley, A. D., Halamka, J., Soundararajan, V.
10.1101/2021.02.15.21251623 — Posted: 2021-02-18 Discussion: Onsite | Offsite
Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 Disease
Serrano, G. E., Walker, J. E., Arce, R., Glass, M. J., Vargas, D., Sue, L., Intorcia, A. J., Nelson, C. M., Oliver, J., Papa, J., Russell, A., Suszczewicz, K. E., Borja, C., Belden, C., Goldfarb, D., Shprecher, D., Atri, A., Adler, C. H., Shill, H. A., Driver-Dunckley, E., Mehta, S. H., Readhead, B., Huentelman, M. J., Peters, J. L., Bimi, C., Mizgerd, J. P., Reiman, E. M., Montine, T. J., Desforges, M., Zehnder, J. L., Sahoo, M. K., Zhang, H., Solis, D., Pinsky, B. A., Deture, M., Dickson, D. W., Beach, T. G.
10.1101/2021.02.15.21251511 — Posted: 2021-02-18
SARS-CoV-2 Seroprevalence Survey Among District Residents Presenting for Serologic Testing at Three Community Based Test Sites in Washington, DC, July to August, 2020
Sherman, A., Reuben, J., David, N. S., Quasie-Woods, D. P., Gunn, J. K. L., Nielson, C. F., Lloyd, P., Yohannes, A., Puckett, M., Powell, J. A., Leonard, S., Iyengar, P., Johnson-Clarke, F., Tran, A., McCarroll, M., Raj, P., Davies-Cole, J., Smith, J., Ellison, J. A., Nesbitt, L.
10.1101/2021.02.15.21251764 — Posted: 2021-02-18
Development and validation of a dynamic 48-hour in-hospital prognostic risk stratification for COVID-19 in a UK teaching hospital: a retrospective cohort study
Wiegand, M., Cowan, S. L., Waddington, C. S., Halsall, D. J., Keevil, V. L., Tom, B. D. M., Taylor, V., Gkrania-Klotsas, E., Preller, J., Goudie, R. J.
10.1101/2021.02.15.21251150 — Posted: 2021-02-18 Discussion: Onsite
Excess Mortality in Suicide caused by COVID-19 in Japan
Kurita, J., Sugishita, Y., Sugawara, T., Ohkusa, Y.
10.1101/2021.02.13.21251670 — Posted: 2021-02-18
COVID-19 Associated Stroke--A Single Centre Experience
Sundar, U., Karnik, N., Mukhopadhyay, A., Darole, P., Kolte, S., Bansal, A., Gokhale, Y., Asole, D., Joshi, A., Pednekar, S., Chavan, S., Trivedi, T., Padwal, N., Kalekar, L., Londhe, C., Padhiyar, R., Pandey, D., Yadav, D., Honrao, S., Bhavsar, P., Shah, P., Gosavi, S., Wadal, A., Shingare, A., Trivedi, M., Pathak Oak, G.
10.1101/2021.02.15.21249420 — Posted: 2021-02-18
A disproportionate epidemic: COVID-19 cases and deaths among essential workers in Toronto, Canada
Rao, A., Ma, H., Moloney, G., Kwong, J., Juni, P., Sander, B., Kustra, R., Baral, S. D., Mishra, S.
10.1101/2021.02.15.21251572 — Posted: 2021-02-18
Optimal Allocation of COVID-19 Vaccines in the Philippines
Buhat, C. A. H., Lutero, D. S., Olave, Y. H., Quindala, K. M., Recreo, M. G. P., Talabis, D. A. S., Torres, M. C., Tubay, J. M., Rabajante, J. F.
10.1101/2021.02.12.21251640 — Posted: 2021-02-18 Discussion: Onsite
Characterization of SARS-CoV-2 genetic structure and infection clusters in a large German city based on integrated genomic surveillance, outbreak analysis, and contact tracing
Walker, A., Houwaart, T., Finzer, P., Ehlkes, L., Tyshaieva, A., Damagnez, M., Strelow, D., Duplessis, A., Nicolai, J., Wienemann, T., Tamayo, T., Kohns Vasconcelos, M., Hülse, L., Hoffmann, K., Lübke, N., Hauka, S., Andree, M., Däumer, M. P., Thielen, A., Kolbe-Busch, S., Göbels, K., Zotz, R., Pfeffer, K., Timm, J., Dilthey, A. T., German COVID-19 OMICS Initiative (DeCOI)
10.1101/2021.02.13.21251678 — Posted: 2021-02-18
Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with build-in screening functionality for DelHV69/70- and N501Y variants such as B.1.1.7
Nörz, D., Grunwald, M., Olearo, F., Fischer, N., Aepfelbacher, M., Pfefferle, S., Lütgehetmann, M.
10.1101/2021.02.12.21251614 — Posted: 2021-02-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).